Successful Treatment with Intravenous Cyclophosphamide for Refractory Adult-Onset Still’s Disease
We report a 64-year-old female case of intractable adult-onset Still’s disease (AOSD). Initial high-dose steroid therapy combined with cyclosporin A was ineffective against macrophage-activation syndrome (MAS), which was accompanied by the systemic type of AOSD. Treatment for MAS with intravenous cy...
Saved in:
| Main Authors: | Yoshika Tsuji, Nozomi Iwanaga, Anna Adachi, Kinuyo Tsunozaki, Yasumori Izumi, Yuji Moriwaki, Kazuhiro Kurohama, Masahiro Ito, Atsushi Kawakami, Kiyoshi Migita |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2015-01-01
|
| Series: | Case Reports in Rheumatology |
| Online Access: | http://dx.doi.org/10.1155/2015/163952 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Granulomatosis with Polyangiitis Presenting as a Choroidal Tumor
by: Taro Masuda, et al.
Published: (2015-01-01) -
Herpes Zoster Meningitis Complicating Combined Tocilizumab and Cyclosporine Therapy for Adult-Onset Still’s Disease
by: Shinichiro Tsurukawa, et al.
Published: (2016-01-01) -
Intravenous iron in heart failure: still no prognostic impact, but questions remain
by: Ibrahim El-Battrawy, et al.
Published: (2025-08-01) -
Cyclophosphamide: An Overview
by: Aditya Kumar Bubna
Published: (2025-01-01) -
Mediterranean fever gene variants may prevent the development of lupus nephritis in Japanese patients with systemic lupus erythematosus
by: Yushiro Endo, et al.
Published: (2025-07-01)